A practical approach for the diagnosis and management of dilated cardiomyopathy

Indian Journal of Pediatrics

Volumn 69, Issue 4, 2002, Pages 341-350

  Kumar, R Krishna ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Childhood cardiomyopathy; Developing country; Diagnosis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARNITINE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENALAPRIL; IMMUNOGLOBULIN; INOTROPIC AGENT; LOSARTAN; VASODILATOR AGENT;

CHILD; CONFERENCE PAPER; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; HEART DILATATION; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HEART VENTRICLE FAILURE; HUMAN; PROGNOSIS;

EID: 0036251771     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723221     Document Type: Conference Paper

References (45)

1. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy
2. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
3. Infantile dilated cardiomyopathy relation of outcome to left evntricular mechanics, hemodynamics and histology at the time of presentation
4. Epidemiology of idiopathic cardiomyopathies in children and adolescents: A nationwide study in Finland
5. On behalf of the National Australian Cardiomyopathy Study. Incidence and outcome of childhood cardiomyopathy in Australia: Results of a ten-year population-based study
6. Pediatric myocardial disease
7. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study
8. The effect of enalapril on survival in patient with reduced left ventricular ejection fraction and congestive heart failure
9. Major advances in pediatric cardiology in the 20th century: II
10. Treatable cardiomyopathies
11. Clinical Approach to Genetic Cardiomyopathy in Children
12. Clinical features of isolated noncompaction of the ventricular myocardium: Long-term clinical course, hemodynamic properties, and genetic background
13. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) - MIM 302060
14. The incidence and evoluation of cardiomyopathy in Duchenne muscular dystrophy
15. X-linked cardiomyopathy (XLCM): Molecular genetic evidene of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus
16. Cardiac troponin T in patients with clinically suspected myocarditis
17. Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy
18. Complications of endomyocardial biopsy in children
19. Endomyocardial biopsy in infants and children with cardiomyopathy
20. Role of right ventricular endomyocardial biopsy in infants and children with suspected or possible myocarditis
21. A clinical trial of immunosuppressive therapy for myocarditis
22. Favorable effects of immunosuppressive therapy in children with delated cardiomyopathy and active myocarditis
23. Myocarditis in children with dilated cardiomyopathy: Incidence and outcome after dual therapy immunosuppression
24. Acute myocarditis. Rapid diagnosis by PCR in children
25. Familial dilated cardiomyopathy in the United Kingdom
26. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy
27. Familial dilated cardiomyopathy
28. Acute hemodynamic effets of captopril in children with a congestive or restrictive cardiomyopathy
29. Beta-blocker therapy in young children with congestive heart failure under consideration for heart transplantation
30. Carvedilol as therapy in pediatric heart failure: An initial multicenter experience
31. Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: A preliminary report
32. The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemica, and pathophysiologic features
33. Carnitine metabolism and deficiency syndromes
34. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy
35. L-carnitine in children with idiopathic dilated cardiomyopathy
36. Gamma-globulin treatment of acute myocarditis in the pediatric population
37. Reduction ventriculoplasty
38. Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy
39. The Registry of the International Society for Heart and Lung Transplantation: Eleventh official report-1994
40. Idiopathic dilated cardiomyopathy in the young: Clinical profile and natural history
41. Prognostic features of children with dilated cardiomyopathy
42. Natural history of dilated cardiomyopathy in children
43. Outcome of infants and childlren with dilated cardiomyopathy
44. Dilated cardiomyopathy in children' determinants of outcome
45. Pediatric dilated cardiomyopathy (DCM): Prognosis in a developing nation is comparable to developed nations